Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : LSBC -- Large Scale Biology Corp. -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (133)	12/18/2003 10:30:05 AM
From: nigel bates	Respond to of 144

VACAVILLE, Calif. (Dow Jones)--Large Scale Biology Corp. (NasdaqNM:LSBC - News) plans to start selling its BAMF technology, which detects cancer and other diseases by identifying biomarkers through blood tests. New York Stock Exchange (News - Websites) -listed shares of Large Scale Biology recently traded at $1.77, up 37 cents, or 26.4%. In a press release Thursday, the drug and diagnostic products maker said results from an ongoing research indicates that BAMF diagnoses ovarian cancer at a 100% rate. Company officials weren't immediately available to discuss the potential market for BAMF or to elaborate on the research.